ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.

Honecker, F; Aparicio, J; Berney, D; Beyer, Jörg; Bokemeyer, C; Cathomas, R; Clarke, N; Cohn-Cedermark, G; Daugaard, G; Dieckmann, K-P; Fizazi, K; Fosså, S; Germa-Lluch, J R; Giannatempo, P; Gietema, J A; Gillessen, Silke; Haugnes, H S; Heidenreich, A; Hemminki, K; Huddart, R; ... (2018). ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Annals of oncology, 29(8), pp. 1658-1686. Oxford University Press 10.1093/annonc/mdy217

[img] Text
2018 Ann Oncol Honecker.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (537kB)

The European Society for Medical Oncology (ESMO) consensus conference on testicular cancer was held on 3-5 November 2016 in Paris, France. The conference included a multidisciplinary panel of 36 leading experts in the diagnosis and treatment of testicular cancer (34 panel members attended the conference; an additional two panel members [CB and K-PD] participated in all preparatory work and subsequent manuscript development). The aim of the conference was to develop detailed recommendations on topics relating to testicular cancer that are not covered in detail in the current ESMO Clinical Practice Guidelines (CPGs) and where the available level of evidence is insufficient. The main topics identified for discussion related to: (1) diagnostic work-up and patient assessment; (2) stage I disease; (3) stage II-III disease; (4) post-chemotherapy surgery, salvage chemotherapy, salvage and desperation surgery and special topics; and (5) survivorship and follow-up schemes. The experts addressed questions relating to one of the five topics within five working groups. Relevant scientific literature was reviewed in advance. Recommendations were developed by the working groups and then presented to the entire panel. A consensus vote was obtained following whole-panel discussions, and the consensus recommendations were then further developed in post-meeting discussions in written form. This manuscript presents the results of the expert panel discussions, including the consensus recommendations and a summary of evidence supporting each recommendation. All participants approved the final manuscript.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Beyer, Jörg, Gillessen, Silke

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

11 Mar 2019 13:42

Last Modified:

05 Dec 2022 15:25

Publisher DOI:

10.1093/annonc/mdy217

PubMed ID:

30113631

BORIS DOI:

10.7892/boris.124927

URI:

https://boris.unibe.ch/id/eprint/124927

Actions (login required)

Edit item Edit item
Provide Feedback